Standard BioTools Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 06/08/2026 BST			5-day change	1st Jan Change
0.8001 ^USD	+2.04%		-10.83%	-37.49%

08-05	Standard BioTools Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-05	Standard Biotools Inc. Withdraws Earnings Guidance for the Full Year 2026	CI

Published on 06/09/2026 at 03:21 am BST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Thank you for joining the Standard BioTools and Treeline Biosciences Merger Announcement Conference Call. I would now like to turn the call over to

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Full unlimited browsing across the entire site

Access to all the news and all the data

Access to US, EUROPE AND ASIA Portfolios

Zero Ads for a completely uninterrupted reading experience

Pro Tools: Expert insights, Expert Screeners, historical financial data and reports, thematic lists, transcripts...

08-05	Standard BioTools Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-05	Standard Biotools Inc. Withdraws Earnings Guidance for the Full Year 2026	CI
07-28	Standard BioTools Sells Mass Cytometry Business Amid Pending Merger With Treeline Biosciences	MT
07-27	Multiplex BioTech Private Limited agreed to acquire Mass Cytometry Business of Standard BioTools Inc. (NasdaqGS : LAB) for $10 million.	CI
06-09	Standard BioTools Inc. - Special Call
06-08	Standard BioTools, Treeline Biosciences to Merge in All-Stock Deal	MT
06-08	Standard BioTools Regains Compliance With Nasdaq's Minimum Bid Price Requirement	MT
05-28	Standard BioTools - approves 2026 change of control and severance plan on May 21, 2026	RE
05-06	Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024.	CI
05-05	Standard BioTools Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	Standard Biotools Inc. Reaffirms Earnings Guidance for Fiscal Year 2026	CI
03-16	Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024.	CI
02-28	Standard BioTools Inc.'s Equity Buyback announced on March 1, 2024, has expired with 13,603,617 shares, representing 7.63% for $35.91 million.	CI
02-24	Standard BioTools Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-24	Standard BioTools Inc. Provides Earnings Guidance for Fiscal Year 2026	CI